Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand

Human Molecular Genetics

Volumn 7, Issue 9, 1998, Pages 1475-1483

  Andersen, Jane ^a   Burns, Helen D ^a   Enriquez Harris, Pita ^a   Wilkie, Andrew O M ^b   Heath, John K ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FIBROBLAST GROWTH FACTOR RECEPTOR; LEUCINE; PROLINE; SERINE; TRYPTOPHAN;

ACROCEPHALOSYNDACTYLY; AMINO ACID SUBSTITUTION; ARTICLE; CRANIOFACIAL SYNOSTOSIS; DISSOCIATION CONSTANT; GENE MUTATION; HUMAN; HUMAN CELL; KINETICS; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR GENE; STOICHIOMETRY;

ACROCEPHALOSYNDACTYLIA; BIOSENSING TECHNIQUES; FIBROBLAST GROWTH FACTORS; HUMANS; KINETICS; LIGANDS; MUTAGENESIS, SITE-DIRECTED; PHENOTYPE; POINT MUTATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT PROTEINS;

EID: 0031683688     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.9.1475     Document Type: Article

References (52)

1. Coulier, F., Pontarotti, P., Roubin, R., Hartung, H., Goldfarb, M. and Birnbaum, D. (1997) Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J. Mol. Evol., 44, 43-56.
2. Givol, D. and Yayon, A. (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J., 6, 3362-3369.
3. Johnson, D.E. and Williams, L.T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60, 1-41.
4. Reardon, W., Winter, R.M., Rutland, P., Pulleyn, L.J., Jones, B.M. and Malcolm, S. (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet., 8, 98-103.
5. Wilkie, A.O.M., Slaney, S.F., Oldridge, M., Poole, M.D., Ashworth, G.J., Hockley, A.D., Hayward, R.D., David, D.J., Pulleyn, L.J. and Rutland, P. (1995) Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet., 9, 165-172.
6. Rutland, P., Pulleyn, L.J., Reardon, W., Baraitser, M., Hayward, R., Jones, B., Malcolm, S., Winter, R.M., Oldridge, M., Slaney, S.F., Poole, M.D. and Wilkie, A.O.M. (1995) Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet., 9, 173-176.
7. Muenke, M., Schell, U., Hehr, A., Robin, N.H., Losken, H.W., Schinzel, A., Pulleyn, L.J., Rutland, P., Reardon, W., Malcolm, S. and Winter, R.M. (1994) Mutations in the fibroblast growth factor receptor-1 gene in Pfeiffer syndrome. Nature Genet., 8, 269-274.
8. Jabs, E.W., Li, X., Scott, A.F., Meyers, G., Chen, W., Eccles, M., Mao, J.I., Charnas, L.R., Jackson, C.E. and Jaye, M. (1994) Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature Genet.. 8, 275-279.
9. Bellus, G.A., Gaudenz, K., Zackai, E.H., Clarke, L.A., Szabo, J., Francomano, C.A. and Muenke, M. (1996) Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genet., 14, 174-176.
10. Meyers, G.A., Day, D., Goldberg, R., Daentl, D.L., Przylepa, K.A., Abrams, L.J., Graham, J.M. Jr, Feingold, M., Moeschler, J.B., Rawnsley, E., Scott, A.F. and Jabs, E.W. (1996) FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am. J .Hum. Genet., 58, 491-498.
11. Przylepa, K.A., Paznekas, W., Zhang, M., Golabi, M., Bias, W., Bamshad, M.J., Carey, J.C., Hall, B.D., Stevenson, R., Orlow, S., Cohen, M.M. Jr and Jabs, E.W. (1996) Fibroblast growih factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nature Genet., 13, 492-494.
12. Wilkie, A.O.M. (1997) Craniosynostosis: genes and mechanisms. Hum. Mol. Genet., 6, 1647-1656.
13. Iseki, S., Wilkie, A.O.M., Heath, J.K., Ishimaru, T., Eto, K. and Morriss-Kay, G.M. (1997) FGFR2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development, 124, 3375-3384.
14. Wilkie, A.O.M., Morriss-Kay, G.M., Jones, E.Y. and Heath, J.K. (1995) Functions of fibroblast growth factors and their receptors. Curr. Biol., 5, 500-507.
15. Bateman, A. and Chothia, C. (1995) Outline structures for the extracellular domains of the fibroblast growth factor receptors. Nature Struct. Biol., 2, 1068-1074
16. Cheon, H.G., LaRochelle, W.J., Bottaro, D.P., Burgess, W.H. and Aaronson, S.A. (1994) High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proc. Natl Acad. Sci. USA, 91, 989-993.
17. Gray, T.E., Eisenstein, M., Shimon, T., Givol, D. and Yayon, A. (1995) Molecular modeling based mutagenesis defines ligand binding and specificity determining regions of fibroblast growth factor receptors. Biochemistry, 34, 10325-10333.
18. Wang, F., Kan, M., Xu, J., Yan, G. and McKeehan, W.L. (1995) Ligand-specific structural domains in the fibroblast growth factor receptor. J. Biol. Chem., 270, 10222-10230.
19. Zimmer, Y., Givol, D. and Yayon, A. (1993) Multiple structural elements determine ligand binding of fibroblast growth factor receptors. J. Biol. Chem., 268, 7899-7903.
20. Slaney, S.F., Oldridge, M., Hurst, J.A., Moriss-Kay, G.M., Hall, C.M., Poole, M.D. and Wilkie, A.O.M. (1996) Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert Syndrome. Am. J. Hum. Genet., 58, 923-932.
21. Moloney, D.M., Slaney, S.F., Oldridge, M., Wall, S.A., Sahlin, P., Stenman, G. and Wilkie, A.O.M. (1996) Exclusive paternal origin of new mutations in Apert syndrome. Nature Genet., 13, 48-53.
22. Oldridge, M., Lunt, P., Zackai, E.H., McDonald-McGinn, D.M., Muenke, M., Moloney, D.M., Twigg, S.R.F., Heath, J.K., Howard, T.D., Hoganson, G., Gagnon, D.M., Jabs, E.W. and Wilkie, A.O.M. (1997) Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. Hum. Mol. Genet., 6, 137-143.
23. Bellus, G.A., Gaudenz, K., Zackai, E.H., Clarke, L.A., Szabo, J., Francomano, C.A. and Muenke, M. (1996) Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genet., 14, 174-176.
24. Galvin, B.D., Hart, K.C., Meyer, A.N. and Webster, M.K. (1996) Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. Proc. Natl Acad. Sci. USA, 93, 7894-7899.
25. Neilson, K.M. and Friesel, R. (1996) Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J. Biol. Chem., 271, 25049-25057.
26. Robertson, S.C., Meyer, A.N., Hart, K.C., Galvin, B.D., Webster, M.K. and Donoghue, D.J. (1998) Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc. Natl Acad. Sci. USA, 95, 4567-4572.
27. Cohn, M.J., Izpisua-Belmonte, J.C., Abud, H., Heath, J.K. and Tickle, C. (1995) Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell. 80, 739-746.
28. Abud, H., Skinner, J.A., McDonald, F.J., Bedford, M.T., Lonai, P. and Heath J.K. (1996) Ectopic expression of FGF-4 in chimeric mouse embryos induces the expression of early markers of limb development in the lateral ridge. Dev. Genet., 181, 51-65.
29. Crossley, P.H., Martinez, S. and Martin, G.R. (1996) Midbrain development induced by FGF8 in the chick embryo. Nature, 380, 66-68.
30. Storey, K.G., Goriely, A., Sargent, C., Burns, H.D., Abud, H. and Heath, J.K. (1998) Early posterior neural tissue is induced by FGF in the chick embryo. Development, 125, 473-484.
31. Champion-Arnaud, P., Ronsin, C., Gilbert, E., Gesnel, M.C., Houssaint, E. and Breath, R. (1991) Multiple mRNAs code for proteins related to the BEK fibroblast factor receptor. Oncogene, 6, 979-987.
32. Karow, J., Hudson, K.R., Hall, M.A., Vernallis, A.B., Taylor, J.A., Gossler, A. and Heath, J.K. (1996) Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor. Biochem. J., 318, 489-495.
33. Oldridge, M., Wilkie, A.O.M., Slaney S.F., Poole, M.D., Pulleyn, L.J., Rutland, P., Hockley, A.D., Wake, M.J.C., Goldin, J.H., Winter, R.M., Reardon, W. and Malcolm, S. (1995) Mutations in the third immunoglobulin domain of the fibroblast growth factor-2 gene in Crouzon syndrome. Hum. Mol. Genet., 4, 1077-1082.
34. Fagerstam, L.G., Frostell, A., Karlsson, R., Kullman, M., Larsson, A., Malmqvist, M. and Butt, H. (1990) Detection of antigen-antibody interactions by surface plasmon resonance. Application to epitope mapping. J. Mol. Recogn., 3, 208-214.
35. Karlsson, R., Michaelsson, A. and Mattsson, L. (1991) Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods, 145, 229-240.
36. Slaney, S.F., Oldridge, M., Hurst, J.A., Moriss-Kay, G.M., Hall, C.M., Poole, M.D. and Wilkie, A.O. (1996) Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am. J. Hum. Genet., 58, 923-932.
37. Spivak-Kroizman, T., Lemmon, M.A., Dikic, I., Ladbury, J.E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J. and Lax, I. (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell, 79, 1015-1024.
38. Vigers, G., Anderson, L.J., Caffes,P. and Brandhuber, B.J. (1997) Crystal structure of the type-1 interleukin-1 receptor complexed with interleukin-1 beta. Nature, 386, 190-193.
39. Schreuder, H., Tardif, C., Trump-Kallmeyer, S., Soffientini, A., Sarubbi, E., Akeson A., Bowlin, T., Yanofsky S, and Barrett, R.W. (1997) A new cytokine receptor binding mode revealed by the crystal strucutre of the IL-1 receptor with an antagonist. Nature, 386, 194-199.
40. Ortega, S., Ittmann, M., Tsang, S.H., Ehrich, M. and Basilico, C. (1998) Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl Acad. Sci. USA, 95, 5672-5677.
41. Zhou, M., Sutliff, R.L., Paul, R.J., Lorenz, J.N., Hoying, J.B., Haudesnschild, C.C., Yin, M.Y., Coffin, J.D., Kong, L., Kranias, E.G., Luo, W.S., Boivin, G.P., Duffy, J., Pawlowski, S.A. and Doetschman, T. (1998) Fibroblast growth factor 2 control of vascular tone. Nature Med., 4, 201-220.
42. Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J. and Hanahan, D. (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell, 66, 1095-1104.
43. Tarantini, F., Gamble, S., Jackson, A. and Maciag, T. (1995) The cysteine residue responsible for the release of fibroblast growth factor-1 residues in a domain independent of the domain for phosphatidylserine binding. J. Biol. Chem., 270, 29039-29042.
44. Shin. J.T., Opalenik, S.R. Wehby, J.N., Mahesh, V.K., Jackson, A., Tarantini, F., Maciag, T. and Thompson, J.A. (1996) Serum-starvation induces the extracellular appearance of FGF-1. Biochim. Biophys. Acta, 1312, 27-38.
45. Shi, J., Friedman, S. and Maciag, T. (1997) A carboxyl-terminal domain in fibroblast growth factor (FGF)-2 inhibits FGF-1 release in response to heat shock in vitro. J. Biol. Chem., 272, 1142-1147.
46. Cheng, G.C., Briggs, W.H., Gerson, D.S., Libby, P., Grodzinsky, A.J., Gray, M.L. and Lee, R.T. (1997) Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. Circ. Res., 80, 28-36.
47. Hansen, B.F., Danielsen, G.M., Drejer, K., Sorensen, A.R., Wiberg, F.C., Klein, H.H. and Lundemose, A.G. (1996) Sustained signalling from the insulin receptor after stimualtion with insulin analogues exhibiting increased mitogenic potency. Biochem. J., 315, 271-279.
48. Shymko, R.M., De Meyts, P. and Thomas, R. (1997) Logical analysis of timing dependent receptor signalling specificity: applications to the insulin receptor metabolic and mitogenic signalling pathways. Biochem J., 326, 463-469.
49. Calver, A.R., Hall, A.C., Yu, W.-P., Walsh, F., Heath, J.K., Betsholtz, C. and Richardson, W.D.R. (1998) Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron, 20, 869-882.
50. Karow, J.H.K., Hall, M.A., Vernallis, A.B., Taylor, J.A., Gossler, A. and Heath, J.K. (1996) Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor. Biochem. J., 318, 489-495.
51. DuBridge, R.B., Tang, P., Hsia, H.C., Leong, P.M., Miller, J.H. and Calos, M.P. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol., 7, 379-387.
52. Pizette, S., Coulier, F., Birnbaum, D. and DeLapeyriere, O. (1996) FGF6 modulates the expression of fibroblast growth factor receptors and myogenic genes in muscle cells. Exp. Cell Res., 224, 143-151.